Outcomes from a phase I trial of an adenovirus/PSA vaccine for prostate cancer

被引：3
|
作者：
Lubaroff, David M.
Konety, Badrinath R.
Link, Brian K.
Ratliff, Timothy L.
Madsen, Tammy
Williams, Richard D.
机构：
来源：
JOURNAL OF UROLOGY | 2008年 / 179卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(08)60534-0
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：184 / 184
页数：1
相关论文
共 50 条
  • [21] A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy
    DeWeese, TL
    van der Poel, H
    Li, SD
    Mikhak, B
    Drew, R
    Goemann, M
    Hamper, U
    DeJong, R
    Detorie, N
    Rodriguez, R
    Haulk, T
    DeMarzo, AM
    Piantadosi, S
    Yu, DC
    Chen, Y
    Henderson, DR
    Carducci, MA
    Nelson, WG
    Simons, JW
    CANCER RESEARCH, 2001, 61 (20) : 7464 - 7472
  • [22] A phase I trial of nordihydroguareacetic acid (NDGA) in patients with non-metastatic prostate cancer and rising PSA
    Harzstark, A. L.
    Ryan, C.
    Diamond, M.
    Jones, J.
    Zavodovskaya, M.
    Maddux, B.
    Claros, C.
    Goldfine, I.
    Small, E. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] A Phase I/II Clinical Trial in Localized Prostate Cancer of an Adenovirus Expressing Nitroreductase with CB1954
    Patel, Prashant
    Young, J. Graham
    Mautner, Vivien
    Ashdown, Daniel
    Bonney, Sarah
    Pineda, Robert G.
    Collins, Stuart I.
    Searle, Peter F.
    Hull, Diana
    Peers, Elizabeth
    Chester, John
    Wallace, D. Michael
    Doherty, Alan
    Leung, Hing
    Young, Lawrence S.
    James, Nicholas D.
    MOLECULAR THERAPY, 2009, 17 (07) : 1292 - 1299
  • [24] Interim results of a phase Ia clinical trial of a PSA, IL-2, GM-CSF containing prostate cancer therapeutic vaccine in PSA defined biochemical recurrent prostate cancer patients
    Head, Jonathan F.
    Daniels, Gregory A.
    McKinney, Michelle A.
    Ongkeko, Weg M.
    Sakamoto, Kyoko
    Wang-Rodriguez, Jessica
    CANCER RESEARCH, 2018, 78 (13)
  • [25] EFFICACY OUTCOMES BY BASELINE PROSTATE-SPECIFIC ANTIGEN (PSA): RESULTS FROM THE PHASE 3 AFFIRM TRIAL
    Saad, Fred
    de Bono, Johann S.
    Shore, Neal D.
    Fizazi, Karim
    Hirmand, Mohammad
    Forer, David
    Scher, Howard I.
    JOURNAL OF UROLOGY, 2013, 189 (04): : E324 - E324
  • [26] Phase II trial of a DNA vaccine with nivolumab in patients with PSA-recurrent, castration-sensitive prostate cancer (nmCSPC)
    McNeel, D. G.
    Emamekhoo, H.
    Eickhoff, J.
    Wargowski, E.
    Liu, G.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1192 - S1192
  • [27] A randomized phase II clinical trial of enzalutamide in combination with the therapeutic cancer vaccine, PSA tricom, in metastatic, castration resistant prostate cancer.
    Singh, Nishith K.
    Kim, Joseph W.
    Heery, Christopher Ryan
    Dahut, William L.
    Couvilion, Anna
    Rauckhorst, Myrna
    McMahon, Sheri
    Schlom, Jeffrey
    Fojo, Tito
    Arlen, Philip M.
    Gulley, James L.
    Madan, Ravi Amrit
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [28] Phase I trial of targeted therapy with PSA-TRICOM vaccine (V) and ipilimumab (ipi) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
    Gulley, James L.
    Madan, Ravi A.
    Tsang, Kwong Y.
    Jochems, Caroline
    Dahut, William L.
    Schlom, Jeffrey
    CANCER RESEARCH, 2013, 73
  • [29] Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer
    Gulley, J
    Chen, AP
    Dahut, W
    Arlen, PM
    Bastian, A
    Steinberg, SM
    Tsang, K
    Panicali, D
    Poole, D
    Schlom, J
    Hamilton, JM
    PROSTATE, 2002, 53 (02): : 109 - 117
  • [30] Phase I trial of targeted therapy with PSA-TRICOM vaccine (V) and ipilimumab (ipi) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Mohebtash, M.
    Madan, R. A.
    Arlen, P. M.
    Rauckhorst, M.
    Tsang, K. Y.
    Cereda, V.
    Vergati, M.
    Poole, D. J.
    Dahut, W. L.
    Schlom, J.
    Gulley, J. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345